Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence
Expert Opinion in Pharmacotherapy, 10/19/09
Mammen K et al. – The addition of naloxone does not appear to affect the efficacy of buprenorphine as a maintenance drug. While offering some deterrence of injection through precipitated withdrawal, there are many circumstances where injecting of buprenorphine–naloxone is reinforcing rather than aversive. The combination will reduce, but not eliminate, intravenous misuse; clinicians therefore need to monitor patients in OST, and be selective in providing patients with medication to be taken without observation.
Related Articles
Systemic opioid and chronic pain
European Journal of Pain, 11/12/09
Relevance Score: 69%
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
Endocrine Reviews, 11/11/09
Relevance Score: 68%
Opioid Use for Chronic Low Back Pain: A Prospective, Population-based Study Among Injured Workers in Washington State, 2002-2005
The Clinical Journal of Pain, 10/20/09
Relevance Score: 68%
Take multiple factors into account when choosing the best opioid for pain therapy in paediatric palliative care
Drugs & Therapy Perspectives, 10/16/09
Relevance Score: 68%
Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia
Clinical Pharmacology & Therapeutics, 11/17/09
Relevance Score: 67%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09
An Open Pilot Study Assessing the Benefits of Quetiapine for the Prevention of Migraine Refractory to the Combination of Atenolol, Nortriptyline, and Flunarizine
Pain Medicine, 12/10/09
Central Levodopa Influx and the Clinical Motor Response to Levodopa in Patients With Parkinson Disease Complicated With Motor Fluctuations and Dyskinesias
Clinical Neuropharmacology, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


